poisar

Stocks · News reference

RBC Capital Downgrades Pentair to Sector Perform, Lowers Price Target to $74

BenzingaJul 15, 2026, 3:41 PMBenzinga Newsdesk

RBC Capital analyst Deane Dray downgrades Pentair (NYSE:PNR) from Outperform to Sector Perform and lowers the price target from $101 to $74.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 15, 2026, 3:41 PM
Checked
Jul 15, 2026, 3:41 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncAug 26, 2026, 1:45 PMKaplan Fox & Kilsheimer Llp

    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role

    Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against Capricor Therapeutics, Pentair plc, and Bloom Energy Corporation on behalf of investors who suffered losses. The primary case involves Capricor, where the FDA released briefing documents revealing that the company made undisclosed changes to its statistical analysis plan for a drug application, resulting in a 64% stock price drop on July 27, 2026.

    Read original at globenewswire-inc